Quantra QStat Sample Type Comparison

A Study to Determine the Inter/Intra Observer and Intra-subject Variability of Whole Blood Clotting Time Measurements

NCT02205827 ·Status: COMPLETED ·Phase: NA

Evaluation of the Inter-center Variability of the Measurement of Thrombin Generation by the ST Genesia System

NCT05422157 ·Status: COMPLETED

Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis

NCT02078154 ·Status: TERMINATED

Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)

NCT00634907 ·Status: COMPLETED ·Phase: NA

The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR

NCT00247702 ·Status: UNKNOWN ·Phase: NA

Effect of New Oral Anticoagulants Dabigatran and Rivaroxaban on Point of Care Coagulation Testing - an Ex-Vivo Study

NCT01704053 ·Status: COMPLETED

Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT

NCT01006733 ·Status: COMPLETED ·Phase: PHASE3

Patient Self Testing of Warfarin Therapy

NCT00594828 ·Status: UNKNOWN ·Phase: PHASE4

Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins

NCT01857050 ·Status: COMPLETED

Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm

NCT00511173 ·Status: COMPLETED ·Phase: PHASE4

Blood Donation From Warfarin Users for the Development of POC INR Monitor

NCT02355730 ·Status: UNKNOWN ·Phase: NA

Assessment of Electrophysiological Effects of Dabigatran Etexilate as Single Dose on the QT Interval in Healthy Female and Male Subjects.

NCT02170987 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence of Two Different Polymorphs of Dabigatran Etexilate in Healthy Male and Female Volunteers

NCT02171481 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Wound Drainage After Knee or Hip Arthroplasty

NCT02054936 ·Status: WITHDRAWN ·Phase: PHASE4

Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra

NCT02270918 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity

NCT01037270 ·Status: COMPLETED

The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings

NCT00830570 ·Status: COMPLETED

A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"

NCT00334464 ·Status: COMPLETED ·Phase: NA

Validation of a Portable Medical Device for Diagnostic in Vitro

NCT02843958 ·Status: COMPLETED ·Phase: NA

Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims Data

NCT05264168 ·Status: COMPLETED

Clotting Genetic Variants, Hormones, and Venous Thrombosis

NCT00094185 ·Status: COMPLETED

Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care

NCT00703963 ·Status: COMPLETED ·Phase: NA

Mutations, Hormone Therapy (HRT) and Venous Thromboembolism

NCT00005515 ·Status: COMPLETED

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

NCT01662908 ·Status: COMPLETED ·Phase: PHASE2

Point-of-Care Testing (POCT) for Guided Precision Anticoagulation With Warfarin: A Multicenter, Non-concurrent Controlled Study

NCT06645275 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4